Lv31
360 积分 2020-04-17 加入
Towards biomarker-driven therapies for urothelial carcinoma
1小时前
已完结
Progress in systemic therapy for advanced-stage urothelial carcinoma
1小时前
已完结
Hypothesis-generating evaluation of multi-armoured oncolytic HSV-1 (VG161) in intrahepatic cholangiocarcinoma: pooled insights from multicentre studies
2个月前
已完结
Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Escalation and Expansion Study
4个月前
已完结
皖公网安备34019202002308
